NASDAQ:CPIX Cumberland Pharmaceuticals (CPIX) Stock Price, News & Analysis $1.47 -0.02 (-1.34%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$1.46▼$1.5150-Day Range$1.40▼$1.6552-Week Range$1.38▼$2.36Volume3,831 shsAverage Volume9,834 shsMarket Capitalization$20.86 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Cumberland Pharmaceuticals alerts: Email Address Ad Weiss RatingsNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. About Cumberland Pharmaceuticals Stock (NASDAQ:CPIX)Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.Read More CPIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CPIX Stock News HeadlinesJuly 26 at 6:39 PM | msn.comMissing NJ woman located along Cumberland RiverJuly 26 at 6:39 PM | msn.comThe Cumberland Valley Family Adventure Trail highlights the best in the area | Travel SmartJuly 26, 2024 | Darwin (Ad)Top Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.July 26 at 5:39 AM | msn.comThese are the Cumberland County Schools Teacher of the Year finalists for 2025July 26 at 12:38 AM | msn.comFriends of missing New Jersey woman shocked after she was found along Cumberland RiverJuly 25 at 7:37 PM | msn.comMissing NJ woman located along Cumberland River in downtown NashvilleJuly 25 at 7:37 PM | msn.comFirst ‘Hub on Campus’ building to open in 2025 as Cumberland Avenue gets new lookJuly 25 at 2:36 PM | msn.comNew plan to enhance family support services in CumberlandJuly 26, 2024 | Darwin (Ad)Top Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.July 25 at 2:36 PM | nj.comWhat $400,000 can buy you in Cumberland CountyJuly 25 at 2:36 PM | yahoo.comSix News in Your Neighborhood: Fairfield Glade in Cumberland CountyJuly 25 at 2:36 PM | msn.comStep back in time at Cumberland County’s Homesteads Towers MuseumJuly 24 at 7:20 AM | msn.comFood hygiene ratings given to 48 Cumberland establishmentsJuly 24 at 7:20 AM | msn.comMan pleads guilty to hit-and-run death of Cumberland County deputyJuly 23 at 9:19 PM | news.yahoo.comTrio charged with trying to sell stolen excavators from Home Depot in Cumberland CountyJuly 23 at 9:19 PM | msn.comFire in solar panel causes $750K in damage to Cumberland buildingJuly 23 at 4:18 PM | news.yahoo.comDriver killed in I-68 crash east of CumberlandJuly 23 at 4:18 PM | msn.comUPS driver caught throwing packages into dumpster in Cumberland County: policeSee More Headlines Receive CPIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/07/2024Today7/26/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals Current SymbolNASDAQ:CPIX CUSIP23077010 CIK1087294 Webwww.cumberlandpharma.com Phone(615) 255-0068Fax615-255-0094Employees91Year Founded1999Profitability EPS (Most Recent Fiscal Year)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,280,000.00 Net Margins-21.67% Pretax Margin-21.52% Return on Equity0.21% Return on Assets0.08% Debt Debt-to-Equity Ratio0.59 Current Ratio1.37 Quick Ratio1.21 Sales & Book Value Annual Sales$39.55 million Price / Sales0.53 Cash Flow$0.68 per share Price / Cash Flow2.16 Book Value$1.96 per share Price / Book0.75Miscellaneous Outstanding Shares14,190,000Free Float8,046,000Market Cap$20.86 million OptionableOptionable Beta0.23 Social Links 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. A. J. Kazimi MBA (Age 66)Founder, Chairman, President & CEO Comp: $952.53kMr. John Michael Hamm (Age 68)VP & CFO Comp: $258.38kMr. James Lowrance Herman (Age 69)Executive VP of National Accounts & Chief Compliance Officer Comp: $372.27kMr. Chris T. Bitterman (Age 59)Vice President of Sales & Marketing Comp: $290.87kMr. Todd M. Anthony (Age 63)Vice President of Organizational Development Comp: $304.94kMs. Jean W. Marstiller (Age 74)Senior VP of Administrative Services & Corporate Secretary Comp: $282.17kMr. Adam S. Mostafa (Age 44)Managing Director Ms. Erin Smith GullSenior Corporate Relations AssociateMore ExecutivesKey CompetitorsAssembly BiosciencesNASDAQ:ASMBRecro PharmaNASDAQ:REPHEli Lilly and CompanyNYSE:LLYJohnson & JohnsonNYSE:JNJMerck & Co., Inc.NYSE:MRKView All Competitors CPIX Stock Analysis - Frequently Asked Questions How have CPIX shares performed this year? Cumberland Pharmaceuticals' stock was trading at $1.7917 at the beginning of 2024. Since then, CPIX shares have decreased by 18.0% and is now trading at $1.47. View the best growth stocks for 2024 here. How were Cumberland Pharmaceuticals' earnings last quarter? Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) issued its quarterly earnings data on Tuesday, May, 7th. The specialty pharmaceutical company reported ($0.06) earnings per share (EPS) for the quarter. The specialty pharmaceutical company had revenue of $8.50 million for the quarter. Cumberland Pharmaceuticals had a positive trailing twelve-month return on equity of 0.21% and a negative net margin of 21.67%. What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO? 9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. How do I buy shares of Cumberland Pharmaceuticals? Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Cumberland Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV) and Akero Therapeutics (AKRO). This page (NASDAQ:CPIX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cumberland Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.